Browse hierarchy: [Anesthesiology (AN)](/submissions/AN) → [Subpart C — Monitoring Devices](/submissions/AN/subpart-c%E2%80%94monitoring-devices) → [21 CFR 868.2378](/submissions/AN/subpart-c%E2%80%94monitoring-devices/868.2378) → QZW — Over-The-Counter Device To Assess Risk Of Sleep Apnea

# QZW · Over-The-Counter Device To Assess Risk Of Sleep Apnea

_Anesthesiology · 21 CFR 868.2378 · Class 2_

**Canonical URL:** https://fda.innolitics.com/submissions/AN/subpart-c%E2%80%94monitoring-devices/QZW

## Overview

- **Product Code:** QZW
- **Device Name:** Over-The-Counter Device To Assess Risk Of Sleep Apnea
- **Regulation:** [21 CFR 868.2378](/submissions/AN/subpart-c%E2%80%94monitoring-devices/868.2378)
- **Device Class:** 2
- **Review Panel:** [Anesthesiology](/submissions/AN)

## Identification

An over-the-counter (OTC) software-only, mobile medical application operating on a compatible Samsung Galaxy Watch and Phone. It is intended to detect signs of moderate to severe obstructive sleep apnea in the form of significant breathing disruptions in adult users 22 years and older, over a two-night monitoring period. It uses software algorithms to analyze input sensor signals (PPG and actigraphy) to provide a risk assessment for sleep apnea. It is not intended to provide a standalone diagnosis, replace traditional methods of diagnosis (e.g., polysomnography), assist clinicians in diagnosing sleep disorders, or be used as an apnea monitor.

## Classification Rationale

Class II (special controls). The device is subject to the general controls of the FD&C Act and the identified special controls.

## Special Controls

In combination with the general controls of the FD&C Act, the over-the-counter device to assess risk of sleep apnea is subject to the following special controls:

## Recent Cleared Devices (2 of 2)

| Record | Device Name | Applicant | Decision Date | Decision |
| --- | --- | --- | --- | --- |
| [K240929](https://fda.innolitics.com/submissions/AN/subpart-c%E2%80%94monitoring-devices/QZW/K240929.md) | Sleep Apnea Notification Feature (SANF) | Apple, Inc. | Sep 13, 2024 | SESE |
| [DEN230041](https://fda.innolitics.com/submissions/AN/subpart-c%E2%80%94monitoring-devices/QZW/DEN230041.md) | Sleep Apnea Feature | Samsung Electronics Co., Ltd. | Feb 6, 2024 | DENG |

## Top Applicants

- Apple, Inc. — 1 clearance
- Samsung Electronics Co., Ltd. — 1 clearance

---

**Source:** [https://fda.innolitics.com/submissions/AN/subpart-c%E2%80%94monitoring-devices/QZW](https://fda.innolitics.com/submissions/AN/subpart-c%E2%80%94monitoring-devices/QZW)

**Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact).

**Cite:** Innolitics at https://innolitics.com